128299-81-0

Upstream product

• 128300-77-6 (4S)-3-(((3'R,4'R,5'S,6'S)-5'-(2-(Benzyloxy)ethyl)bicyclo<2.2.1>hepten-4'-yl)carbonyl)-4-(phenylmethyl)-2-oxazolidinone 
• 128217-56-1 (3'R,4'R,5'S,6'S)-5-(2-(Benzyloxy)ethyl)-4'-carboxybicyclo<2.2.1>heptane 
• 128217-53-8 5-benzyloxy-2(E)-pentenoic acid methyl ester 
• 128217-57-2 (1S,2S,3S,4R)-3-(2-Benzyloxy-ethyl)-bicyclo[2.2.1]hept-2-ylamine 
• 128217-54-9 5-benzyloxy-2-(E)-pentenocarboxylic acid 
• 98-09-9 benzenesulfonyl chloride 
• 132747-46-7 (1S,2S,3S,4R)-3-Carboxy-2-((phenylsulfonyl)amino)bicyclo<2.2.1>heptane 
• 130464-40-3 N-((1S,2S,3S,4R)-3-Formyl-bicyclo[2.2.1]hept-2-yl)-benzenesulfonamide 
• 130464-39-0 (1S,2S,3S,4R)-3-(Hydroxymethyl)-2-((phenylsulfonyl)amino)bicyclo<2.2.1>heptane 
• 130464-41-4 N-[(1S,2S,3R,4R)-3-((E)-2-Methoxy-vinyl)-bicyclo[2.2.1]hept-2-yl]-benzenesulfonamide 
• 128217-59-4 (3'R,4'R,5'S,6'S)-5'-(2-Hydroxyethyl)-4'-benzenesulfonamidobicyclo<2.2.1>heptane 
• 128217-55-0 (4S)-3-(((3'R,4'R,5'S,6'S)-5'-(2-(Benzyloxy)ethyl)bicyclo<2.2.1>heptan-4'-yl)carbonyl)-4-(phenylmethyl)-2-oxazolidinone 
• 128217-58-3 (3'R,4'R,5'S,6'S)-5-(2-(Benzyloxy)ethyl)-4'-benzenesulfonamidobicyclo<2.2.1>heptane 
• 128217-41-4 (4S)-3-((E)-5'-(Benzyloxy)-2'-penetnoyl)-4-(phenylmethyl)-2-oxazolidinone 

Downstream Products

• 112966-96-8 Domitroban 
• 139434-95-0 (1R,2S,3S,4S)-(3-phenylsulfonylaminobicyclo<2.2.1>hept-2-yl)pentamidoethylsulfonic acid 
• 139434-96-1 (1R,2S,3S,4S)-(3-phenylsulfonylaminobicyclo<2.2.1>hept-2-yl)propionamidoethylsulfonic acid 
• 139559-72-1 (1R,2S,3S,4S)-5'-(3-phenylsulfonylaminobicyclo<2.2.1>hept-2-yl)pentanoic acid 
• 139559-73-2 Tetranor-(+)-S-145 
• 139435-17-9 N-[(1S,2S,3S,4R)-3-(3-Oxo-propyl)-bicyclo[2.2.1]hept-2-yl]-benzenesulfonamide 
• 112916-68-4 (Z)-7-((1R,2S,3R,4S)-3-Benzenesulfonylamino-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid 

Relevant academic research and scientific papers

Asymetric Diels-Alder Reactions with γ-Functionalized α,β-Unsaturated Chiral N-Acyloxazolidinones: Synthesis of (+)-S-145

An extension of the asymmetric Diels-Alder cycloaddition with chiral γ-substituted, α,β-unsaturated imides is described.The application of these results to the synthesis of the potent TxA2 receptor antagonist (+)-S-145 was successfully achieved in a practical manner.